Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of FRMD4A mRNA | affects expression | 21346803
|
D004317 |
Doxorubicin |
FRMD4A protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of FRMD4A mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FRMD4A mRNA | affects cotreatment|increases expression | 17942748
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FRMD4A mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of FRMD4A mRNA | increases expression | 19482888
|
D011374 |
Progesterone |
Progesterone results in decreased expression of FRMD4A mRNA | decreases expression | 18070364
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FRMD4A mRNA | affects cotreatment|increases expression | 17942748
|
D019772 |
Topotecan |
FRMD4A protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
9.65 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.65 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.58 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.58 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
11.44 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.44 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.87 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.33 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.14 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.78 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.62 | 15665606 15845082 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.07 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.91 | 15993339 17369602 16826403 15634643 15692762 17983394 16322301 15567936 15994142 16935488 16264153 18234424 18628466 11325840 19526202 15668708 15939500 17426702 16096432 16115903 15136595 18382427 18695136 16595493 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.91 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.91 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.25 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.85 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.85 | 16234567 17876044 16023760 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.85 | 1701930 17173139 20007298 20935162 6705139 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.27 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.70 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.70 | 18627295 16364871 16612575 17519947 16278810 15476868 15792986 16651473 16242529 16269455 16455267 17308081 17924179 16109756 17351982 16731534 15811867 15505089 17974986 17131338 17007740 17329180 16952015 17928571 17382496 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.02 | 16243910 17334414 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.61 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.07 | 17110522 16919318 17333356 17681005 15861022 16105132 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 8697196 16354765 15340226 12621046 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.37 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.85 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.63 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.63 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.63 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.79 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.79 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.31 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.65 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.15 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
10.15 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.62 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.82 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.82 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.60 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.47 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.31 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.01 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.79 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.61 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.41 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.09 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.98 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.52 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.70 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.67 | 12587719 14766674 16244371 18006777 18674790 17875725 16707910 16244372 17888722 16495754 16144979 16330681 16879835 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.50 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.18 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
9.66 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.66 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.65 | 17606976 15147373 18501091 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 16354765 8697196 16959395 15340226 18606429 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.76 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.66 | 17937319 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.41 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.41 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.20 | 15699352 15369732 16775033 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.44 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.21 | 16705839 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.60 | 16085563 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.03 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.50 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.50 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.22 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
4.72 | 19812893 21047994 15975961 19073162 19482888 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
10.81 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
10.81 | 18308698 2563599 17172636 6150874 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.81 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.46 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.46 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.65 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.02 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.93 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.79 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.79 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.32 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.15 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.78 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.19 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.04 | 19429709 15857846 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.87 | 17484760 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.25 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.04 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.13 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.25 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.71 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.71 | 15176712 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.69 | 12819281 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.76 | 17016548 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.34 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.59 | 16525653 17393432 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.57 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.60 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.60 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.87 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11118676 11896295 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.51 | 15749863 18437689 16868541 16729912 16888761 15897917 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.94 | 12752131 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.58 | 17922066 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.93 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.25 | 15625365 18313854 17710206 15675481 16767912 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.57 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.19 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.53 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
6.53 | 16876388 11442880 4039156 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.22 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.07 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.07 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.93 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.38 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.68 | 15862959 16503802 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.03 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
8.03 | 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.49 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.49 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.71 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.58 | 17678736 17334414 17638931 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |